» Authors » Christopher M Callahan

Christopher M Callahan

Explore the profile of Christopher M Callahan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 144
Citations 5722
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuiling M, Shell A, Callahan C, Nurnberger Jr J, MacDonald K, Considine R, et al.
Psychol Med . 2024 Sep; :1-14. PMID: 39252547
Background: Depression is an independent risk factor for cardiovascular disease (CVD), but it is unknown if successful depression treatment reduces CVD risk. Methods: Using eIMPACT trial data, we examined the...
2.
Callahan C, Carter A, Carty H, Clark D, Grain T, Grant S, et al.
Am J Public Health . 2024 Apr; 114(6):619-625. PMID: 38574317
A recent National Academies report recommended that health systems invest in new infrastructure to integrate social and medical care. Although many health systems routinely screen patients for social concerns, few...
3.
Gabbard J, Sadarangani T, Datta R, Fabius C, Gettel C, Douglas N, et al.
J Am Geriatr Soc . 2023 Sep; 71(11):3554-3565. PMID: 37736669
The growing number of people living with dementia (PLWD) requires a coordinated clinical response to deliver pragmatic, evidence-based interventions in frontline care settings. However, infrastructure to support such a response...
4.
Kallmyer B, Bass D, Baumgart M, Callahan C, Dulaney S, Evertson L, et al.
Alzheimers Dement (N Y) . 2023 Aug; 9(3):e12408. PMID: 37533688
Introduction: As the complexity of medical treatments and patient care systems have increased, the concept of patient navigation is growing in both popularity and breadth of application. Patient navigators are...
5.
Tam J, Khurshid K, Sprague B, Clark D, Xu H, Moser L, et al.
Contemp Clin Trials . 2023 Jun; 131:107249. PMID: 37268243
Background: Treatments that delay progression of cognitive impairment in older adults are of great public health significance. This manuscript outlines the protocol, recruitment, baseline characteristics, and retention for a randomized...
6.
Stewart J, Patel J, Polanka B, Gao S, Nurnberger J, MacDonald K, et al.
Brain Behav Immun . 2023 May; 112:18-28. PMID: 37209779
Although depression is a risk and prognostic factor for cardiovascular disease (CVD), clinical trials treating depression in patients with CVD have not demonstrated cardiovascular benefits. We proposed a novel explanation...
7.
Campbell N, Pitts C, Corvari C, Kaehr E, Alamer K, Chand P, et al.
J Am Coll Clin Pharm . 2023 Jan; 5(10):1039-1047. PMID: 36620097
Background: Deprescribing interventions delivered through the electronic medical record have not significantly reduced the use of high-risk anticholinergics in prior trials. Pharmacists have been identified as ideal practitioners to conduct...
8.
Weiner M, Adeoye P, Boeh M, Bodke K, Broughton J, Butler A, et al.
Appl Clin Inform . 2022 Nov; 14(1):37-44. PMID: 36351548
Background: Hypoglycemia (HG) causes symptoms that can be fatal, and confers risk of dementia. Wearable devices can improve measurement and feedback to patients and clinicians about HG events and risk....
9.
Callahan C, Unutzer J
J Am Geriatr Soc . 2022 Jul; 70(9):2484-2486. PMID: 35781250
No abstract available.
10.
Callahan C, Stone R
J Am Geriatr Soc . 2021 Oct; 69(12):3419-3421. PMID: 34642937
No abstract available.